Cardio Diagnostics (CDIOW) Competitors $0.02 0.00 (-11.11%) As of 09/5/2025 03:52 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock CDIOW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CELUW, CEROW, CINGW, CLNNW, and COEPWShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), Clene (CLNNW), and Coeptis Therapeutics (COEPW). These companies are all part of the "biotechnology" industry. Cardio Diagnostics vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Apollomics BriaCell Therapeutics Celularity CERo Therapeutics Cingulate Clene Coeptis Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Is ATNFW or CDIOW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Cardio Diagnostics N/A N/A N/A Does the media refer more to ATNFW or CDIOW? In the previous week, Cardio Diagnostics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Cardio Diagnostics and 0 mentions for 180 Life Sciences. Cardio Diagnostics' average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the news media. Company Overall Sentiment 180 Life Sciences Neutral Cardio Diagnostics Positive Which has preferable valuation & earnings, ATNFW or CDIOW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ACardio Diagnostics$19.51KN/AN/AN/AN/A SummaryCardio Diagnostics beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks. Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIOW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIOW vs. The Competition Export to ExcelMetricCardio DiagnosticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$224.82M$5.83B$9.91BDividend YieldN/A3.78%6.70%4.52%P/E RatioN/A43.3476.2926.13Price / SalesN/A5,216.46532.56172.96Price / CashN/A13.1936.9959.28Price / BookN/A87.2111.486.09Net IncomeN/A-$90.99M$3.29B$266.51M7 Day PerformanceN/A2.30%1.28%0.45%1 Month PerformanceN/A16.90%8.56%5.05%1 Year PerformanceN/A516.57%61.19%26.03% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOWCardio DiagnosticsN/A$0.02-11.1%N/A-58.4%$0.00$19.51K0.007Positive NewsShort Interest ↓Gap DownATNFW180 Life SciencesN/A$0.20-6.3%N/A+2,715.6%$0.00N/A0.007Positive NewsGap DownSXTPW60 Degrees PharmaceuticalsN/A$0.09+0.1%N/AN/A$0.00$641.41K0.002News CoveragePositive NewsGap DownDRTSWAlpha Tau MedicalN/A$0.28-6.0%N/AN/A$0.00N/A0.0080News CoveragePositive NewsGap DownAPLMWApollomicsN/A$0.01+22.8%N/A+38.0%$0.00N/A0.0059Positive NewsGap DownHigh Trading VolumeBCTXWBriaCell TherapeuticsN/A$0.03-15.4%N/A-87.5%$0.00N/A0.008News CoveragePositive NewsShort Interest ↓CELUWCelularityN/A$0.04-31.7%N/A+176.4%$0.00$44.59M0.00220Positive NewsGap DownHigh Trading VolumeCEROWCERo TherapeuticsN/A$0.02-1.6%N/AN/A$0.00N/A0.008Positive NewsShort Interest ↓Gap DownCINGWCingulateN/A$0.06+5.0%N/A+41.4%$0.00N/A0.0020Positive NewsGap DownCLNNWCleneN/A$0.03-12.3%N/A+12.3%$0.00$286K0.00100Positive NewsGap DownCOEPWCoeptis TherapeuticsN/A$0.02-17.5%N/A+20.1%$0.00$263.56K0.004Positive NewsGap Down Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors DRTSW Competitors APLMW Competitors BCTXW Competitors CELUW Competitors CEROW Competitors CINGW Competitors CLNNW Competitors COEPW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDIOW) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.